Publikationen in Zusammenarbeit mit Forschern von Universidad de Salamanca (8)

2024

  1. Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease

    ERJ Open Research, Vol. 10, Núm. 4

2023

  1. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  2. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

  3. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2021

  1. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9

2020

  1. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7

2014

  1. Clinical benefits of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

    Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 34, Núm. 5, pp. 355-359

2010

  1. A qualidade de vida relacionada com a saúde de doentes com doença pulmonar obstrutiva crónica e asma avaliada pelo SGRQ

    Revista Portuguesa de Pneumologia, Vol. 16, Núm. 4, pp. 543-558